Application 211722
- Type
- ANDA
- Sponsor
- TARO PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | SPRAY;TOPICAL | EQ 0.05% BASE/SPRAY | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211722-001 | BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE/SPRAY | SPRAY / TOPICAL | 2020-06-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211722-001 | BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE/SPRAY | SPRAY / TOPICAL | 2020-06-17 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | dc3dd2f7-38ad-4c4c-8602-29b33cc6af90 | 2025-07-07 | Warnings, Adverse reactions | 211722 ANDA211722 51672-1390 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51672-1390 | Betamethasone dipropionate | Betamethasone dipropionate | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 64420 | ORIG | 2020-08-26 |